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Results

Introduction
The cannabis plant (Cannabis Sativa L., aka hemp) produces a variety of compounds
covering numerous chemical classes such as cannabinoids, terpenes, and terpenoids.
The cannabinoid subclass which produces psychoactive and other pharmacological
effects includes chemically neutral and acidic compounds. Cannabinoid acids were
recently proven to be effective at binding to the spike protein of the COVID-19 virus and
thus inhibited cell entry, replication, and infection. Analysis of these compounds can be
performed by numerous techniques including Gas Chromatography-Electron Impact-Mass
Spectrometry (GC-EI-MS). We developed a targeted methodology to analyze four of the
known acids commonly found in consumer products by GC-EI-MS. Since the cannabinoid
acids are prone to decarboxylate at elevated temperatures and revert to their neutral
counterparts (ex. CBDA to CBD, THCA to THC), they are found formulated mainly into
non-smokable consumer products. The elevated temperatures used in GC-EI-MS analysis
necessitated the addition of a protective group to active –OH groups via derivatization.
This methodology proved to be effective at overcoming decarboxylation and allowed the
acids to survive the analysis.
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Figure 1: Peaks at 5.115, 7.130, 9.696, and 11.575 minutes correspond to the fully TMS-derivatized acids.
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Figure 2: Analysis shows the presence of CBDA. Inset data, obtained at much higher concentration, also shows the
presence of CBD and CBDVA. This profile is consistent with the declared concentrations in the product for CBDA, CBD,
and CBDVA (83.422%, 1.452%, and 1.078%, respectively).

Gas Chromatogram of CBDA Cannabis Consumer Product (Gelatin-based)

Analytical Approach
The acids of interest were first derivatized with BSTFA/TMCS which replaces active –OH
groups with thermally stable –OTMS groups, then analyzed by GC-EI-MS (ex. CBDA).
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Experimental
Sample Preparation: DEA-exempt standard solutions of CBDA, CBGA, THCA-A, and
CBDVA were purchased at 1.0 mg/mL in acetonitrile and diluted into stock solutions of 0.1
mg/mL with acetonitrile. The standards were then derivatized by addition of BSTFA
containing 1% TMCS and heated for 30 minutes at 60C. Cannabis consumer products
were either extracted with hexane (gelatin-based) or diluted in acetonitrile (powder) and
derivatized in the same fashion as the standards.
GC-EI-MS Analysis: All analyses were performed on an Agilent 7890A/5975C GC-MSD.

Figure 3: Analysis shows presence of CBD and CBDA. This profile is consistent with the declared concentrations for CBD
and CBDA that were 0.0448 and 0.061%, respectively.

Cannab.
Acid
CBDVA
CBDA
THCA-A
CBGA

Acid MW
(g/mol)
330
358
358
360

Acid-TMS

Acid-TMS MW Ret. Time
(g/mol)
(min)
CBDVA-TMS3
546
5.115
CBDA-TMS3
574
7.13
THCA-A-TMS2
502
9.696
CBGA-TMS3
576
11.575

M+, m/z
546 (1.7%)
574 (1.8%)
502 (2.1%)
576 (1.4%)

M-15, m/z Base ion, m/z
531 (58%)
559 (63%)
487 (100%)
561 (100%)

463 (100%)
491 (100%)
487 (100%)
561 (100%)

Table 1: Molecular weights, retention times, and mass spectral data for cannabinoid acids.

Conclusions/Future Work
• A derivatization method for detection of cannabinoid acid reference standards that effectively eliminated
decarboxylation was developed.
• This method was subsequently used to detect two of the four acids in two different consumer products.
• Future work will include testing a wider variety of consumer products and developing a quantitative
method for the cannabinoid acids.
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References
[1] van Breemen R, Muchiri R, Bates T, Weinstein J, Leier H, Farley D, Tafesse F; Cannabinoids Block Cellular Entry of SARS-CoV-2 and the Emerging
Variants; J of Nat Prod;2022 85;1;176-184.
[2] Ciolino L, Ranieri T, Taylor A; Commercial cannabis consumer products part 1: GC–MS qualitative analysis of cannabis cannabinoids, For. Sci.
Int.; 289:2018;429-437.

CBDA Powder

CBDA Gummy Bears

[3] ElSohly M, Murphy T, Khan I, Walker L, Gula W; Analysis of Cannabidiol, Δ9-Tetrahydrocannabinol, and Their Acids in CBD Oil/Hemp Oil
Products; Medical Cannabis and Cannabinoids;2020;3;1-13.

